Functionalized nanoparticles for measurement of biomarkers using a SERS nanochannel platform

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7577, Issue , 2010, Pages

  Benford, Melodie ^a   Wang, Miao ^b   Kameoka, Jun ^b   Good, Theresa ^c   Cote, Gerard ^a  

^a Texas A M University   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Baltimore County   (United States)

Author keywords

C reactive protein; Cardiac biomarker; Colloidal gold; Competitive immunoassay; Nanochannel; Nanofluidic device; Point of care diagnostics; Raman spectroscopy; SERS; Surface enhanced

Indexed keywords

C-REACTIVE PROTEINS; CARDIAC BIOMARKERS; COLLOIDAL GOLD; COMPETITIVE IMMUNOASSAY; NANO CHANNELS; NANO-FLUIDIC DEVICES; POINT-OF-CARE DIAGNOSTICS;

ANTIBODIES; ANTIGENS; GOLD; HEART; IMMUNOLOGY; NANOFLUIDICS; NANOPARTICLES; PLASMONS; RAMAN SCATTERING; RAMAN SPECTROSCOPY; SURFACES;

BIOMARKERS;

EID: 77951616319     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.842486     Document Type: Conference Paper

References (23)

1. Blomkalns, A.L. and W.B. Gibler, "Early Detection of Myocardial Necrosis in the Emergency Setting and Utility of Serum Biomarkers in Chest Pain Unit Protocols," in [Cardiac Markers], A.H.B. Wu, Editor. Humana Press, 3-13 (2003).
2. Graff, L.G., et al., "Impact on the Care of the Emergency Department Chest Pain Patient from the Chest Pain Evaluation Registry (CHEPER) Study." The American Journal of Cardiology. 80(5), 563-568 (1997).
3. Wu, A.H.B., ed. [Cardiac Markers.] 2nd ed. Pathology and Laboratory Medicine, ed. S. Sell and A.H.B. Wu., Humana Press (2003).
4. Newby, L.K., et al., "Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study." Circulation. 103, 1832- 1837 (2001).
5. Mair, J., et al., "Equivalent Early Sensitivities of Myoglobin, Creatine Kinase MB Mass, Creatine Kinase Isoform Ratios, and Cardiac Troponins I and T for Acute Myocardial Infarction." Clinical Chemistry. 41(9), 1266-1272 (1995).
6. Canto, J.G., et al., "Prevalence, Clinical Characteristics. and Mortality Among Patients With Myocardial Infarction Presenting Without Chest Pain." Journal of the American Medical Association. 283(24), 3223-3229 (2000).
7. Patel, M.R., et al., "Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative." American Heart Journal. 152, 641-647 (2006).
8. Hamm, C.W., "Cardiac Biomarkers for Rapid Evaluation of Chest Pain." Circulation. 104, 1454-1456 (2001).
9. Antman, E.M., et al.," ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction." Circulation. 110, 588-636 (2004).
10. Price, C.P., "Point of care testing." British Medical Journal. 322(7291), 1285-1288 (2001).
11. Collinson, P.O., "Cardiac Marker Measurement by Point-of-Care Testing," in Cardiac Markers, A.H.B. Wu, Editor. Humana Press, 199-212 (2003).
12. Jaffe, A.S. and H. Katus, "Acute Coronary Syndrome Biomarkers: The Need for More Adequate Reporting." Circulation. 104-6 (2004).
13. Panteghini, M., et al., "Standardization of immunoassays for measurement of myoglobin in serum. Phase I: Evaluation of candidate secondary reference materials." Clinica Chimica Acta. 341, 65-72 (2004).
14. Panteghini, M., The Measurement of Cardiac Markers: Where Should We Focus? American Journal of Clinical Pathology. 118, 354-361 (2002).
15. Benford, M., et al., "Detection of Cardiac Biomarkers Exploiting Surface Enhaned Raman Scattering (SERS) Using a Nanofluidic Channel Based Biosensor Towards Coronary Point-of-Care Diagnostics." Proceedings of SPIE. 7192 (2009).
16. Wang, M., et al., "Optofluidic device for ultra-sensitive detection of proteins using surface-enhanced Raman spectroscopy." Microfluidics and Nanofluidics. 6(3), 411-417 (2009).
17. Chou, I.-H., et al., "Nanofluidic Biosensing for β-amyloid Detection Using Surface Enhanced Raman Spectroscopy." Nano Letters. 8(6), 1729-1735 (2008).
18. Wang, M., et al., "An optofluidic device for surface enhanced Raman spectroscopy." Lab on a Chip. 7, 630-632 (2007).
19. Benford, M., et al., "In vitro detection of beta amyloid exploiting surface enhanced Raman scattering (SERS) using a nanofluidic biosensor." Proceedings of SPIE. 6869 (2008).
20. "AlexaFluor Protein Labeling Kit", Molecular Probes, (2004).
21. "Carbolink Kit," Pierce Biotechnology, (2003).
22. Michaels, A.M., M. Nirmal, and L.E. Brus, "Surface Enhanced Raman Spectroscopy of Individual Rhodamine 6G Molecules on Large Ag Nanocrystals." Journal of the American Chemical Society. 121, p. 9932-9939 (1999).
23. Li, G., et al., "Completely reversible aggregation of nanoparticles by varying the pH." Colloid and Polymer Science. 281, 1099-1103 (2003).